Abstract
The search for effective pharmaceutical agents which possess high antiaggregant and antioxidant activity, and simultaneously, lack negative side effects, is a highly relevant task for modern science. In this regard, we evaluated the antiplatelet activity of a new conjugated compound from acetylsalicylic acid and carnosine—salicyl-β-alanil-L-histidine (salicyl-carnosine, SC) and investigate the antioxidant activity of SC in an in vitro model of Fe2+-induced chemoluminiscence of low and very low density lipoproteins, acquired from blood of patients with chronic cerebrovascular diseases (CCVD). The acquired results indicate that the effectiveness of SC in reducing ADP-induced thrombocyte aggregation in vitro is comparable to that of acetylsalicylic acid. At the same time, carnosine and salicylic acid failed to demonstrate any significant antiaggregant effect. All investigated compounds had a similar effect on lipid hydro-peroxides levels, and effectively decreased them in a range of concentrations from 50 to 500 µM. The observed antioxidant activity of compounds, occurred proportionately to their concentration. In conclusion, SC possesses both antiaggregant and antioxidant activity, which is maintained in CCVD patient blood samples in vitro. This new compound has the potential to become an effective pharmaceutical agent for treating cerebrovascular disease.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
REFERENCES
Suslina, Z.A., Tanashyan, M.M., and Domashenko, M.A., Annals Clin. Exp. Neurol., 2007, vol. 1, no. 1, pp. 10–16 [In Russ].
Haybar, H., Khodadi, E., Zibara, K., and Saki, N., Cardiovasc. Hematol. Disord. Drug Targets, 2018, vol. 18, no. 2, pp. 153–161.
Raber, I., McCarthy, C.P., Vaduganathan, M., Bhatt, D.L., Wood, D.A., Cleland, J.G.F., Blumenthal, R.S., and McEvoy, J.W., Lancet, 2019, vol. 393, no. 10186, pp. 2155–2167.
Gu, Y., Sheng, R., Wu, J., Zhou, Y., and Qin, Z.-H., Thromb. Res., 2018, no. 171, pp. 121–129.
Donnan, G.A., Fisher, M., Macleod, M., and Davis, S.M., Lancet, 2008, no. 371, pp. 1612–1623.
Kiernan, T.J., Yan, B.P., and Jaff, M.R., J. Vasc. Surg., 2009, no. 50, pp. 431–439.
Tanashyan, M.M., Raskurazhev, A.A., and Kuznetsova, P.I., Profilakticheskaya meditsina, 2018, vol. 21, no. 5, pp. 124–129.
Fiolaki, A., Katsanos, A.H., Kyritsis, A.P., Papadaki, S., Kosmidou, M., Moschonas, I.C., Tselepis, A.D., and Giannopoulos, S., J. Neurol. Sci., 2017, no. 376, pp. 112–116.
Antithrombotic Trialists’ Collaboration, BMJ, 2002, vol. 324, no. 7329, pp. 71–86.
Meade, E.A., Smith, W.L., and DeWitt, D.L., J. Biol. Chem., 1993, vol. 268, no. 9, pp. 6610–6614.
Hankey, G.J., and Eikelboom, J.W., Lancet., 2006, vol. 367, no. 9510, pp. 606–617.
Hovens, M.M.C., Snoep, J.D., Eikenboom, J.C.J., van der Bom, J.G., Mertens, B.J., and Huisman, M.V., Am. Heart J., 2007, vol. 153, no. 2, pp. 175–181.
Fitzgerald, R., and Pirmohamed, M., Pharmacol. Ther., 2011, V. 130, no. 2, pp. 213–225.
Hovens, M.M.C., Snoep, J.D., Groeneveld, Y., Tamsma, J.T., Eikenboom, J.C., and Huisman, M.V., J. Thromb. Haemost., 2007, vol. 5, no. 7, pp. 1562–1564.
Cattaneo, M., J. Thromb. Haemost., 2007, no. 5, pp. 230–237.
Jeon, S.B., Song, H.S., Kim, B.J., Kim, H.J., Kang, D.W., and Kim, J.S., Eur. Neurol., 2010, no. 64, pp. 51–57.
Ozben, S., Ozben, B., Tanrikulu, A.M., Ozer, F., and Ozben, T., J. Neurol., 2011, no. 258, pp. 1979–1986.
Tanashyan, M.M., Domashenko, M.A., and Raskurazhev, A.A., Annals. Clin. Exp. Neurol., 2016, vol. 10, no. 1, pp. 41–46. [In Russ].
Alberts, M.J., Bergman, D.L., Molner, E., Jovanovic, B.D., Ushiwata, I., and Teruya, J., Stroke, 2004, vol. 35, no. 1, pp. 175–8.
Yi, X., Zhou, Q., Lin, J., and Chi, L., Int. J. Stroke, 2013, no. 8, pp. 535–539.
Zheng, A.S.Y., Churilow, L., Colley, R.E., Goh, C., Davis, S.M., and Yan, B., JAMA Neurol., 2013, no. 70, pp. 208–213.
Kim, J.T., Suk-Hee, H., Lee, J.S., Choi, M.J., Choi, K.H., and Nam, T.S., PLoS One, 2015, no. 10, p. e0120743.
Adam, F., Khatib, A.M., Lopez, J.J., Vatier, C., Turpin, S., Muscat, A., Soulet, F., Aries, A., Jardin, I., Bobe, R., Stepanian, A., de Prost, D., Dray, C., Rosado, J.A., Valet, P., Feve, B., and Siegfried, G., Blood, 2016, no. 127, pp. 908–920.
Needs, C. J., and Brooks, P. M., Clin. Pharmacokinet., 1985, vol. 10, no. 2, pp. 164–77.
Choi, H.W., Tian, M., Song, F., Venereau, E., Preti, A., Park, S.W., Hamilton, K., Swapna, G.V., Manohar, M., Moreau, M., Agresti, A., Gorzanelli, A., De Marchis, F., Wang, H., Antonyak, M., Micikas, R.J., Gentile, D.R., Cerione, R.A., Schroeder, F.C., Montelione, G.T., Bianchi, M.E., and Klessig, D.F., Mol. Med., 2015, vol. 21, no. 1, pp. 526–535.
Pisoschi, A.M., and Pop, A., Eur. J. Med. Chem., 2015, vol. 5, no. 97, pp. 55–74.
Piradov, M.A., Tanashyan, M.M., Domashenko, M.A., Sergeev, D.V., and Maksimova, M.Yu., Annals Clin. Exp. Neurol., 2015, vol. 9, no, 1. pp. 41–50. [In Russ].
Fuster, V., Dyken, M. L., Vokonas, P. S., and Hennekens, C., Circulation, 1993, vol. 87, no. 2, pp. 659–675.
Baltazar, M.T., Dinis-Oliveira, R.J., Duarte, J.A., Bastos, M.L., and Carvalho, F., Curr. Med. Chem., 2011, vol. 18, no. 21, pp. 3252–3264.
Berezhnoy, D.S., Stvolinsky, S.L., Lopachev, A.V., Devyatov, A.A., Lopacheva, O.M., Kulikova, O.I., Abaimov, D.A., and Fedorova, T.N., Amino Acids., 2019, no. 51, pp. 139–150.
Tanashyan, M.M., Fedorova, T.N., Stvolinskij, S.L., Andreeva, L.A., Nagaev, I.Y., Migulin, V.A., Shabalina, A.A., Trubitsyna, I.E., Lopachev, A.V., Kulikova, O.I., and Abaimov, D.A. Agent possessing antiaggregant, cytoprotective and antioxidant activity. RU 2694061 C1.
Kulikova, O.I., Stvolinsky, S.L., Migulin, V.A., Andreeva, L.A., Nagaev, I.Y., Lopacheva, O.M., Kulichenkova, K.N., Lopachev, A.V., Trubitsina, I.E., and Fedorova, T.N., Daru, 2020, vol. 28, no. 1, pp. 119–130.
Trubitsyna, I.E., Stvolinsky, S.L., Kulikova, O.I., Fedorova, T.N., Tarasova, T.B., Efremov, L.I., Mikhailova, S.F., and Varvanina, G.G., Eksperimental’naia i klinicheskaia gastroenterologiia, 2019, vol. 163, no. 3, pp. 58–64. [In Russ]
Fedorova, T. N., Logvinenko, A. A., Poleshchuk, V. V., and Illarioshkin, S. N., Neurochemical J., 2017, vol. 11, no. 4, pp. 340–345.
Grootveld, M., and Halliwell, B., Biochem. J., 1986. V. 237. no. 2. pp. 499–504.
Shi, X., Ding, M., Dong, Z., Chen, F., Ye, J., Wang, S., Leonard, S. S., Castranova, V., and Vallyathan V., Mol. Cell. Biochem., 1999, V. 199, no. 1–2, pp. 93–102.
Steer, K.A., Wallace, T.M., Bolton C.H., and Hartog, M., Heart, 1997, vol. 77, no. 4, pp. 333–337.
Dressman, J.B., Nair, A., Abrahamsson, B., Barends, D.M., Groot, D.W., Kopp, S., Langguth, P., Polli, J.E., Shah, V.P., and Zimmer, M., J. Pharm. Sci., 2012, no. 101, pp. 2653–2667.
Tanashjan, M.M., Khamidova, Z.M., Ionova, V.G., Kostyreva, M.V., and Shabalina, A.A. Method for detecting antiplatelet drug resistance in patients with progressing cerebral atherosclerosis. 2013. RU 2478965 C1
Born, G.V., Nature, 1962, vol. 194, no. 37, pp. 927–929.
Shabalina, A.A., Tanashyan, M.M., Kuznetsova, P.I., Khamidova, Z.M., and Roitman, E.V., Thromb. Res., 2021, vol. 200, no. 1, p. S78.
Mirzoian, R.S., Shabalina, A.A., Gan’shina, T.S., Kurdyumov, I.N., Turilova, A.I., Kostochka, L.M., Kozlov, A.V., Annushkin, V.A., Kornilova, A.A., and Tanashyan, M.M., Annals Clin. Exp. Neurol., 2020, vol. 14, no. 3, pp. 53–59. [In Russ].
Stvolinsky, S.L., Bulygina, E.R, Fedorova, T.N., Meguro, K., Sato, T., Tyulina, O.V., Abe, H., and Boldyrev, A.A., Cell. Mol. Neurobiol., 2010, no. 30, pp. 395–404.
Funding
This work was supported by state assignment Ministry of Education and Science of the Russian Federation for Research Center of Neurology no. АААА-А20-120052790037-4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare no competing interests.
Ethical approval. All procedures performed in human research comply with the ethical standards of the Institutional Research Ethics Committee and the Declaration of Helsinki (1964) and its subsequent amendments.
Informed consent. Informed consent was obtained from each of the participants included in the study.
Additional information
Correspondence address: Volokolamskoe sh. 80, Moscow, 125367 Russia; phone: +7-495-490-24-09; e-mail: kulikova@neurology.ru
Rights and permissions
About this article
Cite this article
Kulikova, O.I., Fedorova, T.N., Shabalina, A.A. et al. Anti-Aggregation and Antioxidant Properties of a New Derivative of Acetylsalicylic Acid and Carnosine. Neurochem. J. 16, 472–479 (2022). https://doi.org/10.1134/S1819712422040146
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712422040146